Status: Recruiting
A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects
This is a single-centre, randomised, open-label, single-dose, two-cycle, double-crossover study to compare the pharmacokinetics of SJ04 and Ovidrel® in healthy female subjects. Received a single subcutaneous injection administration of SJ04 Injection or Ovidrel®, both administered at a dose of 250 μg, once per cycle, and cross-administered after a washout period.
Participants needed: 48
Trial details
Phase: Phase 1Age: 20-40Biological sex: FemaleType: InterventionalSponsor: Suzhou Centergene Pharmaceuticals Co.,Ltd.Updated: Feb 10, 2025Locations: 1
Eligibility criteria
Healthy female subjects aged 20 to 40 years old (including boundary values). [+4]
Allergy or suspected allergy to any component of the experimental drug, control... [+18]